An 18-year-old patient has developed new suicidal thoughts after starting escitalopram (Lexapro); what immediate steps should be taken?

Immediate Management of New Suicidal Thoughts in 18-Year-Old on Lexapro

Stop the Lexapro immediately and conduct an urgent suicide risk assessment to determine if psychiatric hospitalization is needed. This patient is experiencing a known serious adverse effect of SSRI treatment in young adults, and immediate intervention is critical to prevent self-harm 1.

Immediate Steps (Within 24 Hours)

1. Discontinue Escitalopram

• Stop the medication now—do not wait for a psychiatry consultation 2
• The FDA black-box warning specifically identifies increased suicidal thoughts in patients through age 24, particularly in the first months of treatment or after dose changes 3, 1
• The absolute risk is approximately 1% with antidepressants versus 0.2% with placebo, but when it occurs, it requires immediate action 3

2. Conduct Urgent Suicide Risk Assessment

High-risk indicators requiring immediate psychiatric hospitalization 4:

• Current intent to die or active plan for suicide
• Recent suicide attempt with high lethality
• Severe hopelessness or agitation
• Impulsivity with low self-control
• Substance use disorder
• Lack of supportive family or inability to ensure safety monitoring
• Refusal to engage in safety planning

Lower-risk indicators potentially manageable outpatient 4:

• Suicidal thoughts without intent or plan
• Responsive and supportive family present
• Patient expresses desire for help
• Someone available for continuous monitoring
• Ability to commit to immediate mental health follow-up

3. Environmental Safety Measures (Mandatory Regardless of Risk Level)

Means restriction is critical—most adolescent/young adult suicide attempts are impulsive, with 24% occurring within 5 minutes of decision 5:

• Remove all firearms from the home (not just locked—physically removed to another location) 5
• Lock up all medications, both prescription and over-the-counter 4
• Remove knives and other potential means 5
• Restrict access to means in homes of friends/relatives where patient may visit 5

Disposition Decision Algorithm

Hospitalize if ANY of the following:

• Active suicidal intent or plan
• Previous suicide attempts
• Severe depression with agitation
• Behavioral activation/akathisia (restlessness, impulsivity, disinhibition) 3, 6
• Family unwilling or unable to provide 24/7 monitoring
• Substance use present
• Patient refuses safety planning

Outpatient management ONLY if ALL of the following:

• No intent or plan, only passive thoughts
• Supportive family committed to monitoring
• Immediate (same-day or next-day) mental health appointment secured
• Patient agrees to safety plan
• All lethal means removed from environment
• Patient can articulate reasons for living

Important Clinical Nuances

Behavioral Activation vs. Suicidality

The patient may be experiencing behavioral activation/agitation rather than true worsening depression 3. This presents as:

• Motor or mental restlessness
• Insomnia
• Impulsiveness
• Disinhibited behavior
• Irritability

This typically occurs early in SSRI treatment and improves rapidly after discontinuation 3. However, it can be dangerous in the acute phase and may have contributed to the suicidal thoughts 6.

The Black-Box Warning Context

While the FDA black-box warning has been controversial, with some reanalyses showing only a 0.7% increased risk 4, when suicidal ideation does emerge, it must be taken seriously. The number needed to harm is 143, but for this individual patient, the harm has occurred 3.

Medication Considerations Going Forward

• Do not restart escitalopram in this patient
• If antidepressant treatment is needed after stabilization, fluoxetine is the only FDA-approved SSRI for adolescents with depression and has the most evidence 2
• Starting at higher doses increases suicide risk—always use lowest starting doses 2
• Consider psychotherapy (CBT or IPT-A) as first-line treatment instead of medication 2

Follow-Up Monitoring

If outpatient management is chosen (which should be rare in this scenario):

• Contact within 24-48 hours (phone or in-person) 2
• Weekly monitoring for first month minimum 2
• Assess for worsening depression, new suicidal thoughts, behavioral changes
• Ensure family understands warning signs and has crisis numbers

The safest course is psychiatric hospitalization for complete evaluation in a protected environment, even though no controlled studies prove this saves lives 4. The risk of not hospitalizing a young adult with new-onset suicidal thoughts on an SSRI is too high to manage in most outpatient settings.